Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: Test-negative case-control studies using surveillance data, Spain, 2003-2011

Vaccine

Volumn 32, Issue 35, 2014, Pages 4404-4411

  Savulescu, Camelia ^a   Jiménez Jorge, Silvia ^a,b   Delgado Sanz, Concha ^a,b   de Mateo, Salvador ^a,b   Pozo, Francisco ^c   Casas, Inmaculada ^c   Larrauri, Amparo ^a,b  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Case control studies; Effectiveness; Influenza; Sentinel surveillance; Vaccines and immunisation

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; HUMAN; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEASON; SEASONAL INFLUENZA; SENTINEL SURVEILLANCE; SEX DIFFERENCE; SPAIN; SPANISH INFLUENZA; TREATMENT OUTCOME; CHILD; FEMALE; IMMUNOLOGY; INFANT; INFLUENZA VIRUS A H3N2; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SPAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904391455     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.06.063     Document Type: Article

References (36)

1. World Health Organization Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec 2012, 87:461-476.
2. Ministry of Health and Social Policy [Internet], Spain. Influenza prevention. Recommendations for influenza vaccination [In Spanish], [updated 2014; cited 2014 Jun 24]〈http://www.msps.es/ciudadanos/enfLesiones/enfTransmisibles/gripe/home.htm〉.
3. Ministry of Health and Health Policies [Internet], Spain. Vaccination campaign for the pandemic influenza virus H1N1 2009-Official recommendations [In Spanish], 2009 [cited 2014 Jun 24], (http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/vacunas/2009/docs/NI_campana-vacunacion-H1N1_recomendaciones-oficiales.pdf〉.
4. Ministry of Health and Health Policies [Internet], Spain. Evolution of influenza vaccination coverage in population ≥65 years. National total between seasons 1996-1997 and 2012-2013 [In Spanish], [updated 2014; cited 2014 Jun 24], (http://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/coberturas.htm〉.
5. World Health Organization [Internet] WHO interim global epidemiological surveillance standards for influenza 2012, World Health Organization. http://www.who.int/influenza/resources/documents/influenza_surveillance_manual/en/index.html.
6. Larrauri A., De Mateo S. Characterization of swabbing for virological analysis in the Spanish Influenza Sentinel Surveillance System during four influenza seasons in the period 2002-2006. EuroSurveillance 2007, 12(5). [2013 December 15]. http://www.eurosurveillance.org/ViewArticle.aspx%3FArticleId=706.
7. European Centre for Disease Prevention and Control [Internet]. About European Influenza Network, [updated 2014; cited 2014 Jun 24], (http://ecdc.europa.eu/en/activities/surveillance/eisn/about_eisn/pages/about_network.aspx〉.
8. E. Negro, A. Larrauri, S. de Mateo [Internet]. Evaluation of the Sentinel Networks integrated in the Spanish Influenza Surveillance System [In Spanish], [updated 2008; cited 2014 Jun 24], (http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/EvaluacionredescentinelaSVGE.pdf).
9. Larrauri Cámara A., Jiménez-Jorge S., De Mateo Ontañón S., Pozo Sánchez F., Ledesma Moreno L., Casas Flecha I., the Spanish Influenza Surveillance System (SISS) Epidemiology of the 2009 influenza pandemic in Spain. The Spanish Influenza Surveillance System. Enferm Infecc Microbiol Clin 2012, 30(Supl. 4):2-9.
10. Fleming D.M., Andrews N.J., Ellis J.S., Bermingham A., Sebastianpillai P., Elliot A.J., et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010, 64:1062-1067.
11. Kelly H., Carville K., Grant K., Jacoby P., Tran T., Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009, 4:1-7.
12. Skowronski D.M., Janjua N.Z., De Serres G., Winter A.L., Dickinson J.A., Gardy J.L., et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season. Clin Infect Dis 2012, 55:332-342.
13. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31(17):2165-2168.
14. De Serres G., Skowronski D.M., Wu X.W., Ambrose C.S. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. EuroSurveillance 2013, 18(37). pii=20585. http://www.eurosurveillance.org/ViewArticle.aspx%3FArticleId=20585.
15. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31(30):3104-3109.
16. Savulescu C., Jiménez-Jorge S., de Mateo S., Pozo F., Casas I., Breña P.P., et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. BMC Public Health 2011, 11:899.
17. Larrauri A., Savulescu C., Jiménez-Jorge S., Pérez-Breña P., Pozo F., Casas I., et al. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain. Gac Sanit 2011, 25:23-28.
18. ICHPPC-2-Defined. International Classification of Health Problems in Primary Care. 3rd edn. Oxford, Oxford University Press, 1983.
19. European Commission [Internet]. Commission Decision of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council, OJ L 2611/1, 27.9.12, [updated 2012; cited 2014 Jun 24], (http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L: 2012:262:0001:0057:EN:PDF〉.
20. Institute of Health Carlos III [Internet], Spain. Annual and weekly National Influenza Reports. Spanish Influenza Surveillance System. [In Spanish], [updated 2014; cited 2014 Jun 24], 〈〉 in press. http://www.isciii.es/cne-gripe-infsemanal.
21. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infect Dis 2012, 12:36-44.
22. Osterholm MT, Kelley NS, Manske JM, Ballering KS, Leighton TR, Moore KA [Internet]. The Compelling need for game-changing influenza vaccines. An analysis of the influenza vaccine enterprise and recommendations for the future. CIDRAP report, 2012, [updated 2012; cited 2014 Jun 24], 〈〉. http://www.cidrap.umn.edu/sites/default/files/public/downloads/ccivi_report.pdf.
23. Belongia E.A., Kieke B.A., Donahue J.G., Coleman L.A., Irving S.A., Meece J.K., et al. Influenza vaccine effectiveness in Wisconsin during the 2007-2008 season: comparison of interim and final results. Vaccine 2011, 29:6558-6563.
24. Fielding J.E., Grant K.A., Papadakis G., Kelly H.A. Estimation of type and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008. BMC Infect Dis 2011, 11:170.
25. Janjua N.Z., Skowronski D.M., De Serres G., Dickinson J., Crowcroft N.S., Taylor M., et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis 2012, 205(12):1858-1868.
26. Skowronski D.M., De Serres G., Dickenson J., Petric M., Mak A., Fonseca K., et al. Component-specific effectiveness of the trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009, 199:168-179.
27. Skowronski D.M., Masaro C., Kwindt T.L., Mak A., Petric M., Li Y., et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007, 25:2842-2851.
28. Simpson C.R., Lone N., Kavanagh K., Ritchie L.D., Robertson C., Sheikh A., et al. Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study-exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine. Health Serv Delivery Res 2013, 7(5):729-737. 10.1111/irv.12018.
29. Kelly H., Sullivan S.G., Grant K.A., Fielding J.E. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. Influenza Other Respir Viruses 2012, 10.1111/irv.12018.
30. Herrera G.A., Iwane M.K., Cortese M., Brown C., Gershman K., Shupe A., et al. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine 2007, 25:154-160.
31. Ohmit S.E., Victor J.C., Rotthoff J.R., Teich E.R., Truscon R.K., Baum L.L., et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006, 355(24):2513-2522.
32. Jiménez-Jorge S., Savulescu C., Pozo F., de Mateo S., Casas I., Ledesma J., cycEVA Study Team, Spanish Influenza Sentinel Surveillance System, et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012, 30(24):3595-3602.
33. Savulescu C., Valenciano M., de Mateo S., Larrauri A., cycEVA Study Team Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine 2010, 28(16):2903-2907.
34. Nichol K.L., Mendelman P. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses. Virus Res 2004, 103:3-8.
35. Nichol K.L. Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. Vaccine 2006, 24:6726-6728.
36. Diaz Granados C.A., Denis M., Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012, 31:49-57.